HOME >> BIOLOGY >> NEWS
Early treatment can prevent severe vision loss in premature infants

A new study by specialists at the Johns Hopkins Children's Center and 25 other institutions nationwide for the first time gives eye doctors a precise way to identify premature babies at the highest risk of abnormal blood vessel growth in the retina and subsequent blindness. The computerized risk assessment tool they used should lead to treatment of retinopathy of prematurity (ROP) at its earliest stages, stopping or limiting both loss of vision and structural damage to the eye.

"Before this study, we did not have a precise clinical model to follow to help predict which infants will ultimately develop vision loss from ROP, so we often had to defer treatment until the disease reached the treatment 'threshold,' at which point there was still a 25 percent chance of retinal detachment," says Michael Repka, M.D., a pediatric ophthalmologist at the Children's Center, and a member of the study team. "Unfortunately, delaying therapy to that point leaves some infants with vision loss."

Using both old and new criteria, researchers were able to identify which premature infants enrolled in the study were at highest risk for blindness. Results of their study, published in the December issue of the Archives of Ophthalmology, show that early treatment significantly reduced the likelihood of poor vision from 19.5 to 14.5 percent at about one year of age. Early treatment also reduced the likelihood of structural damage to the eye from 15.6 to 9.1 percent.

According to Repka, ROP presents ophthalmologists with difficult treatment decisions because the disease can be highly unpredictable. In many infants, he says, it can spontaneously improve and spare the child's vision, while in others, it can suddenly progress and result in blindness.

For the study, the researchers identified 499 out of 828 infants diagnosed at birth with ROP as being at higher than usual risk for vision loss, based on the computerized guide that assessed birth weight, ethnicity,
'"/>

Contact: Jessica Collins
jcolli31@jhmi.edu
410-516-4570
Johns Hopkins Medical Institutions
8-Dec-2003


Page: 1 2

Related biology news :

1. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
2. Early detection hope for eye disease
3. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
4. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects
5. Early predictor of breast cancer aggressiveness
6. Early treatment confirmed as key to stroke recovery
7. Early identification of kidney disease cost-effective only when directed at high-risk patients
8. Early promise for treatment of Ebola
9. Early hominids may have behaved more human than we had thought
10. Early infection and rejection detection
11. Early-life environments shape development of stress behaviors and learning abilities in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/2/2018)... ... ... fun-loving eight-year-old Labrador retriever. Like many labs, Stuart’s favorite thing in the world is ... that whenever anyone comes to our door, he grabs a toy to greet them, just ... Stuart began limping and eventually could no longer play fetch. Though he was still ...
(Date:10/1/2018)... , ... October 01, 2018 , ... ... targeted antibody drug conjugate (ADC) like, lipid based therapeutics, today announced the ... Program had confirmed the award of first year funding for two separate grants. ...
(Date:10/1/2018)... ... October 01, 2018 , ... ... the nation’s elderly, stories surrounding such facilities are dire. Lawsuits dot the ... provider, which alleges that the chain’s “callous and profit-driven approach” has had “devastating” ...
Breaking Biology News(10 mins):
(Date:9/22/2018)... ... 2018 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it will be co-hosting a workshop with BASF Corporation ... one-day event is to be held at the Hilton Boston Back Bay hotel, ...
(Date:9/15/2018)... LINDA, Calif. (PRWEB) , ... September 14, 2018 , ... ... treat patients. But even with new technologies, challenges remain. In the past, the sheer ... , St. Jude Cloud is a new data ecosystem developed to advance cures ...
(Date:9/13/2018)... ... , ... Asymmetrex’s director, James L. Sherley, M.D., Ph.D., asks audiences ... we didn’t have the means to measure the number of drug molecules in drug ... that is what’s holding up progress in stem cell medicine.” , “Can you imagine ...
(Date:9/12/2018)... ... September 11, 2018 , ... Leading regenerative veterinary ... Feline Practitioners Conference (AAFP) later this month. The company’s CEO and ... for the treatment of chronic kidney disease in felines at a poster session ...
Breaking Biology Technology:
Cached News: